🗣️ Kicking things off with Johanna S. Enke, MD of @UCLAHealthJCCC discussing a trial evaluating lutetium Lu 177 vipivotide tetraxetan in prostate cancer.

More overage on our site!

#ESMO26 @myESMO #pcsm #oncology